Compare · CDW vs WGS
CDW vs WGS
Side-by-side comparison of CDW Corporation (CDW) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDW and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- CDW is the larger of the two at $17.00B, about 11.0x WGS ($1.55B).
- CDW has been more active in the news (4 items in the past 4 weeks vs 3 for WGS).
- CDW has more recent analyst coverage (25 ratings vs 8 for WGS).
- Company
- CDW Corporation
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $17.00B
- $1.55B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2013
- 2020
- News (4w)
- 4
- 3
- Recent ratings
- 25
- 8
CDW Corporation
CDW Corporation provides integrated information technology (IT) solutions to business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products, as well as integrated IT solutions, including on-premise, hybrid and cloud capabilities across data center and networking, digital workspace, security, and virtualization. Its hardware products comprise notebooks/mobile devices, network communications, desktop computers, video monitors, enterprise and data storage, and other hardware; and software products include application suites, security, virtualization, operating systems, and network management. The company also provides field services, managed services, warranties, configuration services, partner services, and telecom services. CDW Corporation was founded in 1984 and is based in Lincolnshire, Illinois.
Latest CDW
- Director Nelms David W bought $2,005,740 worth of shares (18,000 units at $111.43), increasing direct ownership by 55% to 51,025 units (SEC Form 4)
- CDW upgraded by Analyst with a new price target
- CDW Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Officer Leahy Christine A bought $499,398 worth of shares (4,830 units at $103.39), increasing direct ownership by 3% to 193,357 units (SEC Form 4)
- Officer Tan Hang was granted 33,802 shares (SEC Form 4)
- Officer Locy Peter R was granted 1,950 shares, increasing direct ownership by 49% to 5,903 units (SEC Form 4)
- CDW Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- CDW Authorizes $1 Billion Share Repurchase Program Increase
- New insider Tan Hang claimed no ownership of stock in the company (SEC Form 3)
- SEC Form 10-Q filed by CDW Corporation
Latest WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)